All Articles

SAP NS2's new high-security authorization for its cloud ERP allows it to challenge tech giants and accelerate the Pentagon's digital transformation.

A new Bernstein report reveals UHNW families are prioritizing internal resilience and next-gen prep over external market fears, driven by new laws and a deep generational divide.

New data reveals elevated cortisol in over 75% of hard-to-treat diabetes patients, paving the way for a novel drug to tackle treatment resistance.

QTREX Quantum's electronics 3D printing tech achieved 97% yield at a top US manufacturer, moving to the production floor. A quantum leap for electronics.

A new study offers hope for MS by promoting nerve repair, but the real story is the validation of a versatile stem cell platform for a new era of medicine.

Vendors hold the cards in IT renewals. A new platform aims to change that by arming enterprises with pre-quote intelligence to secure better deals.

Fate Therapeutics' new board appointment signals a major shift. Can a commercial veteran turn groundbreaking iPSC science into accessible, off-the-shelf medicine?

Facing a 'going concern' warning and collapsing revenue, Splash Beverage Group is ditching drinks for drugs. Its investment in Avicanna is a desperate, yet strategic, pivot.

The AI revolution is built on massive data centers, but their immense power needs and complex risks are forcing the insurance industry into a high-stakes race to innovate.

With a June 29 deadline, the Global Procurement Awards 2026 offer a final chance for leaders to gain recognition for tech-driven, strategic excellence.

Team Boxing League's new regional deal isn't just about sports; it's a calculated move in the high-stakes game of media disruption and audience capture.

A new partnership between Klick Labs and Mayo Clinic aims to detect disease using your voice. But what does this mean for the future of our health systems?

As the Port of Trois-Rivières posts a sharp drop in cargo, its leaders are betting a $312M overhaul will secure its future. But is it a sound investment?

Amidst a crisis in higher education, Bennington College's appointment of a psychoanalyst-artist-scholar as president is more than a hire—it's a bold strategy.

The APEC China CEO Forum and Supply Chain Expo signal a strategic play, linking high-level trade policy with on-the-ground industrial execution.

A small Houston firm's modular waste-to-methanol plant in Porto is more than a green project; it's a strategic blueprint for European energy sovereignty.

New data shows a national drop in overdose deaths, but a closer look reveals a fractured reality with regional surges and a dangerous new drug cocktail.

A single AML patient's journey to a stem cell transplant after treatment with CER-1236 offers a glimmer of hope, but is it a breakthrough or a mirage?

A landmark deal sees REIT giant VICI Properties partner with Club Med to resurrect a St. Croix icon, signaling a strategic shift in hospitality investment.

For decades, patients with advanced chondrosarcoma had no options. Now, a new drug's journey to the FDA offers a lifeline and a lesson in medical neglect.